90 related articles for article (PubMed ID: 24767802)
1. The serological profiles of subgroup of primary Sjögren's syndrome correlation with the clinical features of parotid glands.
Zheng L; Yu C; Yang C; Xie L; Shi H; Wang Z
J Craniomaxillofac Surg; 2014 Oct; 42(7):1260-4. PubMed ID: 24767802
[TBL] [Abstract][Full Text] [Related]
2. [The role of parotid gland biopsy in early detection of lymphoma in primary Sjogren's syndrome].
Vasil'iev VI; Logvinenko OA; Probatova NA; Kokosadze NV; Gorodetskiĭ VR; Kovrigina AM; Kondrat'eva TT; Mitrikov BV; Gaĭduk IV; Safonova TN; Simonova MV; Radenska-Lopovok SG; Varlamova EIu
Ter Arkh; 2009; 81(6):20-7. PubMed ID: 19663187
[TBL] [Abstract][Full Text] [Related]
3. Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy.
Hamza N; Bootsma H; Yuvaraj S; Spijkervet FK; Haacke EA; Pollard RP; Visser A; Vissink A; Kallenberg CG; Kroese FG; Bos NA
Ann Rheum Dis; 2012 Nov; 71(11):1881-7. PubMed ID: 22615459
[TBL] [Abstract][Full Text] [Related]
4. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
Zadura AF; Theander E; Blom AM; Trouw LA
Scand J Immunol; 2009 Apr; 69(4):374-80. PubMed ID: 19284503
[TBL] [Abstract][Full Text] [Related]
5. Hyperviscosity in primary Sjögren's syndrome: clinical implications.
Hernández-Molina G; Bermúdez-Bermejo P
Int J Rheum Dis; 2017 Jan; 20(1):84-89. PubMed ID: 26807556
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation and salivary gland histopathology of paediatric primary Sjögren's syndrome.
Saad Magalhães C; de Souza Medeiros PB; Oliveira-Sato J; Custódio-Domingues MA
Clin Exp Rheumatol; 2011; 29(3):589-93. PubMed ID: 21640054
[TBL] [Abstract][Full Text] [Related]
7. Ig gene analysis reveals altered selective pressures on Ig-producing cells in parotid glands of primary Sjögren's syndrome patients.
Hamza N; Hershberg U; Kallenberg CG; Vissink A; Spijkervet FK; Bootsma H; Kroese FG; Bos NA
J Immunol; 2015 Jan; 194(2):514-21. PubMed ID: 25488989
[TBL] [Abstract][Full Text] [Related]
8. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.
Gottenberg JE; Busson M; Cohen-Solal J; Lavie F; Abbed K; Kimberly RP; Sibilia J; Mariette X
Ann Rheum Dis; 2005 Jul; 64(7):1050-5. PubMed ID: 15640273
[TBL] [Abstract][Full Text] [Related]
9. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients.
Baldini C; Pepe P; Quartuccio L; Priori R; Bartoloni E; Alunno A; Gattamelata A; Maset M; Modesti M; Tavoni A; De Vita S; Gerli R; Valesini G; Bombardieri S
Rheumatology (Oxford); 2014 May; 53(5):839-44. PubMed ID: 24369420
[TBL] [Abstract][Full Text] [Related]
10. Reversible parotid enlargement and pseudo-Sjögren's syndrome secondary to hypertriglyceridemia.
Sheikh JS; Sharma M; Kunath A; Fritz DA; Glueck CJ; Hess EV
J Rheumatol; 1996 Jul; 23(7):1288-91. PubMed ID: 8823709
[TBL] [Abstract][Full Text] [Related]
11. ESSPRI and other patient-reported indices in patients with primary Sjogren's syndrome during 100 consecutive outpatient visits at one rheumatological clinic.
Pertovaara M; Korpela M
Rheumatology (Oxford); 2014 May; 53(5):927-31. PubMed ID: 24464708
[TBL] [Abstract][Full Text] [Related]
12. [Clinical usefulness of Beta2microglobulin in patients with Primary Sjögren Syndrome].
Rozzatti MS; Fontaneto E; Pedano V; Racca A; Pelosso M; Gobbi C; Alba P; Demarchi M
Rev Fac Cien Med Univ Nac Cordoba; 2015; 72(1):7-15. PubMed ID: 26273943
[TBL] [Abstract][Full Text] [Related]
13. Expression of interferon regulatory factor 1, 3, and 7 in primary Sjögren syndrome.
Zheng L; Yu C; Zhang Z; Yang C; Cai X
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):661-8. PubMed ID: 19426920
[TBL] [Abstract][Full Text] [Related]
14. Sjögren's syndrome: correlation between histopathologic result and clinical and serologic parameters.
Giuca MR; Bonfigli D; Bartoli F; Pasini M
Minerva Stomatol; 2010 Apr; 59(4):149-54, 154-7. PubMed ID: 20360662
[TBL] [Abstract][Full Text] [Related]
15. Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment.
Delli K; Haacke EA; Kroese FG; Pollard RP; Ihrler S; van der Vegt B; Vissink A; Bootsma H; Spijkervet FK
Ann Rheum Dis; 2016 Nov; 75(11):1933-1938. PubMed ID: 26757748
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypes and clinical features of lymphocytes in the labial gland of primary Sjogren's syndrome patients.
Sun W; Zhang N; Zhang Y; Shao Z; Gong L; Wei W
J Clin Lab Anal; 2018 Nov; 32(9):e22585. PubMed ID: 29923220
[TBL] [Abstract][Full Text] [Related]
17. Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren's syndrome.
Huo AP; Lin KC; Chou CT
Int J Rheum Dis; 2010 Feb; 13(1):39-47. PubMed ID: 20374383
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of serum galectin-3 in patients with primary Sjögren's syndrome: associated with interstitial lung disease.
Zhang R; Sun T; Song L; Zuo D; Xiao W
Cytokine; 2014 Oct; 69(2):289-93. PubMed ID: 24981072
[TBL] [Abstract][Full Text] [Related]
19. Growth Arrest-Specific 6 Protein in Patients with Sjögren Syndrome: Determination of the Plasma Level and Expression in the Labial Salivary Gland.
Chen CH; Chen HC; Chang CC; Peng YJ; Lee CH; Shieh YS; Hung YJ; Lin YF
PLoS One; 2015; 10(10):e0139955. PubMed ID: 26445266
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin-17 in primary Sjögren's syndrome: association with disease duration and parotid gland swelling.
Alunno A; Bistoni O; Caterbi S; Bartoloni E; Cafaro G; Gerli R
Clin Exp Rheumatol; 2015; 33(1):129. PubMed ID: 25536226
[No Abstract] [Full Text] [Related]
[Next] [New Search]
